Search research articles
Contact Us
Filters
Showing results (541-550 of 544) with videos related to
Page
of 55
Sort By:
You have reached the last page of results.
This site can display upto 544 results.
Leukemia
|
January 13, 2019
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
Detlef Haase, Kristen E Stevenson, Donna Neuberg, et al.
Nature Cancer
|
February 5, 2022
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
Annika Fendler, Lewis Au, Scott T C Shepherd, et al.
Research Square
|
September 28, 2021
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
Annika Fendler, Lewis Au, Scott T C Shepherd, et al.
Mayo Clinic Proceedings
|
July 28, 2015
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs
Ayalew Tefferi, Hagop Kantarjian, S Vincent Rajkumar, et al.
Page
of 55
Search research articles
Search
Showing results (541-550 of 544) with videos related to
Sort By:
Page
of 55
You have reached the last page of results.
This site can display upto 544 results.
Leukemia
|
January 13, 2019
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
Detlef Haase, Kristen E Stevenson, Donna Neuberg, et al.
Nature Cancer
|
February 5, 2022
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
Annika Fendler, Lewis Au, Scott T C Shepherd, et al.
Research Square
|
September 28, 2021
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
Annika Fendler, Lewis Au, Scott T C Shepherd, et al.
Mayo Clinic Proceedings
|
July 28, 2015
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs
Ayalew Tefferi, Hagop Kantarjian, S Vincent Rajkumar, et al.
Page
of 55